Accessibility Menu
 
Praxsyn logo

Praxsyn

(OTC) PXYN

Current Price$0.00
Market Cap$600
Since IPO (2010)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Praxsyn Financials at a Glance

Market Cap

$600

Revenue (TTM)

$20.47M

Net Income (TTM)

$2.68M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

7.82 (High)

Price

$0.00

Volume

108,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PXYN News

No articles available.

PXYN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Praxsyn

Industry

Pharmaceuticals

Headquarters

Las Vegas, IL, US

PXYN Financials

Key Financial Metrics (TTM)

Gross Margin

29%

Operating Margin

-2%

Net Income Margin

-7%

Return on Equity

0%

Return on Capital

-8%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00

Shares Outstanding

634.67M

Volume

108.00K

Short Interest

0.00%

Avg. Volume

4.46K

Financials (TTM)

Gross Profit

$23.91K

Operating Income

$196.00K

EBITDA

$139.00K

Operating Cash Flow

$23.72M

Capital Expenditure

$67.70K

Free Cash Flow

$23.79M

Cash & ST Invst.

$4.17K

Total Debt

$1.65M

Praxsyn Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2019YOY CHG

Revenue

$41.93K

-99.8%

Gross Profit

$24.46K

-99.8%

Gross Margin

58.33%

N/A

Market Cap

$600.00

N/A

Market Cap/Employee

$9.09

N/A

Employees

66

N/A

Net Income

$142.00K

-104.5%

EBITDA

$117.00K

-102.1%

Quarterly Fundamentals

Name
Q3 2019YOY CHG

Net Cash

$1.81M

-247.5%

Accounts Receivable

$11.06M

+54.5%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$2.10M

-38.4%

Return on Assets

-5.08%

N/A

Return on Invested Capital

-7.78%

N/A

Free Cash Flow

$5.90M

+14.6%

Operating Cash Flow

$5.77M

+16.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RBIIRising BioSciences, Inc.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%
LRDSFLords & Company Worldwide Holdings Inc.
$0.00+0.00%
SPPHSpencer Pharmaceutical Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About PXYN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.